Other Stories

WHO lists China's Sinopharm COVID-19 vaccine for emergency use Updated: 2021-05-08 12:10:07 KST

The World Health Organization has approved China's COVID-19 vaccine Sinopharm for emergency use, the first vaccine made by a non-western country to get approval.
The organization cited a group of experts on immunization having recommended two doses of the vaccine for adults over 18 years-old with a spacing of three to four weeks.
It added vaccine efficacy was estimated to be 79 percent, but efficacy could not be estimated for people aged 60 or older due to fewer clinical trials for that age group.
The WHO listing for emergency use is a prerequisite for the COVAX Facility vaccine supply.
Others listed are Pfizer, AstraZeneca, Serum Institute of India, Janssen and Moderna vaccines.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.